Opus Genetics (IRD) Change in Accured Expenses (2010 - 2026)
Opus Genetics (IRD) reported Change in Accured Expenses of $432000.0 for Q1 2026, up 58.82% year-over-year from $272000.0 in Q1 2025, and up 149.48% on a QoQ basis from -$873000.0 in Q4 2025.
Opus Genetics (IRD) has 17 years of Change in Accured Expenses data on file, last reported at $432000.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 58.82% year-over-year to $432000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (down 179.08% YoY) and the FY2025 annual result came in at -$3.5 million, down 161.59% from the prior year.
- Change in Accured Expenses grew to $432000.0 in Q1 2026 per IRD's latest filing, from -$873000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.4 million in Q4 2024 and bottomed at -$1.9 million in Q2 2025.
- The 5-year median for Change in Accured Expenses is $1000.0 (2022), against an average of $157882.4.
- The widest annual swing landed in 2023, when Change in Accured Expenses surged 149700.0%; it then plunged 1109.94% in 2025.
- Tracing IRD's Change in Accured Expenses over 5 years: stood at $461000.0 in 2022, then tumbled by 125.16% to -$116000.0 in 2023, then jumped by 2129.31% to $2.4 million in 2024, then slumped by 137.09% to -$873000.0 in 2025, then jumped by 149.48% to $432000.0 in 2026.
- Per Business Quant, the three latest IRD Change in Accured Expenses figures stand at $432000.0 (Q1 2026), -$873000.0 (Q4 2025), and -$946000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 432,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 432,000.00 |
| Mar 31, 2026 | 432,000.00 |
| Dec 31, 2025 | -873,000.00 |
| Dec 31, 2025 | -873,000.00 |
| Sep 30, 2025 | -946,000.00 |
| Sep 30, 2025 | -946,000.00 |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | 272,000.00 |
| Mar 31, 2025 | 272,000.00 |
| Dec 31, 2024 | 2.35 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | -161,000.00 |
| Jun 30, 2024 | -161,000.00 |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | -116,000.00 |
| Dec 31, 2023 | -116,000.00 |
| Sep 30, 2023 | -1.51 Mn |
| Sep 30, 2023 | -1.51 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 247,000.00 |
| Mar 31, 2023 | 247,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Sep 30, 2022 | -194,000.00 |
| Sep 30, 2022 | -194,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -319,000.00 |
| Mar 31, 2022 | -319,000.00 |
| Dec 31, 2021 | 612,000.00 |
| Dec 31, 2021 | 612,000.00 |
| Sep 30, 2021 | 49,000.00 |
| Sep 30, 2021 | 49,000.00 |
| Jun 30, 2021 | 347,000.00 |
| Jun 30, 2021 | 347,000.00 |
| Mar 31, 2021 | -1.16 Mn |
| Mar 31, 2021 | -1.16 Mn |
| Dec 31, 2020 | 1.23 Mn |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 239,000.00 |
| Sep 30, 2020 | 239,000.00 |
| Jun 30, 2020 | -8,000.00 |
| Jun 30, 2020 | -8,000.00 |
| Mar 31, 2020 | -200,000.00 |
| Mar 31, 2020 | -200,000.00 |
| Dec 31, 2019 | 2.25 Mn |
| Dec 31, 2019 | 2.25 Mn |
| Sep 30, 2019 | -554,519.00 |
| Sep 30, 2019 | -554,519.00 |
| Jun 30, 2019 | -325,466.00 |
| Jun 30, 2019 | -325,466.00 |
| Mar 31, 2019 | -906,350.00 |
| Mar 31, 2019 | -906,350.00 |
| Dec 31, 2018 | -179,096.00 |
| Dec 31, 2018 | -179,096.00 |
| Sep 30, 2018 | -50,047.00 |
| Sep 30, 2018 | -50,047.00 |
| Jun 30, 2018 | 332,672.00 |
| Jun 30, 2018 | 332,672.00 |
| Mar 31, 2018 | -184,905.00 |
| Mar 31, 2018 | -184,905.00 |
| Dec 31, 2017 | 895,149.00 |
| Dec 31, 2017 | 895,149.00 |
| Sep 30, 2017 | 534,769.00 |
| Sep 30, 2017 | 534,769.00 |
| Jun 30, 2017 | 88,522.00 |
| Jun 30, 2017 | 88,522.00 |
| Mar 31, 2017 | -167,014.00 |
| Mar 31, 2017 | -167,014.00 |
| Dec 31, 2016 | 96,776.00 |
| Dec 31, 2016 | 96,776.00 |
| Sep 30, 2016 | -8,923.00 |
| Sep 30, 2016 | -8,923.00 |
| Jun 30, 2016 | -1.49 Mn |
| Jun 30, 2016 | -1.49 Mn |
| Mar 31, 2016 | 622,969.00 |
| Mar 31, 2016 | 622,969.00 |
| Dec 31, 2015 | -576,765.00 |
| Dec 31, 2015 | -576,765.00 |
| Sep 30, 2015 | 69,255.00 |
| Sep 30, 2015 | 69,255.00 |
| Jun 30, 2015 | 419,269.00 |
| Jun 30, 2015 | 419,269.00 |
| Mar 31, 2015 | 290,276.00 |
| Mar 31, 2015 | 290,276.00 |
| Dec 31, 2014 | 733,755.00 |
| Dec 31, 2014 | 733,755.00 |
| Sep 30, 2014 | 185,657.00 |
| Sep 30, 2014 | 185,657.00 |
| Jun 30, 2014 | 661,351.00 |
| Jun 30, 2014 | 661,351.00 |
| Mar 31, 2014 | -55,258.00 |
| Mar 31, 2014 | -55,258.00 |
| Dec 31, 2013 | 183,516.00 |
| Dec 31, 2013 | 183,516.00 |
| Sep 30, 2013 | 130,175.00 |
| Sep 30, 2013 | 130,175.00 |
| Jun 30, 2013 | -356,099.00 |
| Jun 30, 2013 | -356,099.00 |
| Mar 31, 2013 | 124,329.00 |
| Mar 31, 2013 | 124,329.00 |
| Dec 31, 2012 | -19,670.00 |
| Dec 31, 2012 | -19,670.00 |
| Sep 30, 2012 | -19,460.00 |
| Sep 30, 2012 | -19,460.00 |
| Jun 30, 2012 | -129,044.00 |
| Jun 30, 2012 | -129,044.00 |
| Mar 31, 2012 | -165,394.00 |
| Mar 31, 2012 | -165,394.00 |
| Dec 31, 2011 | -2.72 Mn |
| Dec 31, 2011 | -2.72 Mn |
| Sep 30, 2011 | 13,844.00 |
| Sep 30, 2011 | 13,844.00 |
| Jun 30, 2011 | 951,982.00 |
| Jun 30, 2011 | 951,982.00 |
| Mar 31, 2011 | 1.12 Mn |
| Mar 31, 2011 | 1.12 Mn |
| Dec 31, 2010 | 479,728.00 |
| Dec 31, 2010 | 479,728.00 |
| Sep 30, 2010 | -268,767.00 |
| Sep 30, 2010 | -268,767.00 |